FLGT Q2 2017 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$449M

Q2 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M+16.8% YoY

Gross Profit

$3M59.5% margin

Operating Income

-$150,000-3.2% margin

Net Income

-$25,000-0.5% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

-12.6%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$62,000

Stock-Based Comp.

$424,000

Balance Sheet

Total Assets

$59M

Total Liabilities

$3M

Stockholders' Equity

$56M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+16.8%
Gross Profit	$3M	$3M	+7.9%
Operating Income	-$150,000	$970,000	-115.5%
Net Income	-$25,000	-$5M	+99.4%

Geographic Segments

UNITED STATES

$2M49%

CANADA

$1M25%

Other Countries

$684,00015%

CHINA

$522,00011%